Background
Tumor initiating stem-like cells (TISCs), also defined as cancer stem cells, are a subpopulation of neoplastic cells that possess distinct survival and regeneration mechanisms important for chemotherapy resistance and disease progression [
1,
2]. By definition, TISCs possess stem cell features including resistance to apoptosis and self-renewal [
3‐
5]. After their initial discovery and characterization within hematological malignancies [
6,
7], TISCs have now been described in many different malignancies including hepatocellular carcinoma (HCC) [
8,
9]. Further evidence supports that HCC arises as a direct consequence of dysregulated proliferation of hepatic progenitor cells [
10,
11]. Transcriptome analysis of HCC demonstrated that a progenitor-based (TISC-phenotype) expression profile is associated with a poor prognosis compared to differentiated tumors (hepatocyte-phenotype) [
12‐
14].
Resistance to therapy and metastatic disease are two factors that correlate a TISC-phenotype HCC with poor survival. TISCs are hypothesized to be the source of metastatic lesions, as a tumor-initiating cell [
15]. Although this hypothesis remains controversial, recent work establishes a connection between epithelial-mesenchymal-transition (EMT) and a TISC-phenotype [
16,
17]. EMT is a critical developmental process that plays a central role in the formation and differentiation of multiple tissues and organs. During EMT, epithelial cells lose cell-cell adhesion and apical-polarity, and acquire mesenchymal features, such as motility, invasiveness, and resistance to apoptosis [
18].
One of the key hallmarks of EMT is loss of E-cadherin, a cell-adhesion protein that is regulated by multiple transcription factors including Snail, Slug, and Twist. These transcription factors act as E-box repressors and block E-cadherin transcription [
18]. In cancer biology, EMT is one mechanism to explain the invasive and migratory capabilities that epithelial carcinomas acquire during metastasis [
19,
20]. In HCC, increased expression of the E-cadherin repressors Twist and Snail correlates with poor clinical outcomes [
21]. In breast cancer, EMT is associated with the acquisition of a TISC CD44
+/CD24
low phenotype [
17,
22].
One of the major inducer of EMT is transforming growth factor-β (TGFβ), a multifunctional cytokine that regulates cell proliferation, differentiation and apoptosis [
23]. In early stages of carcinogenesis, TGFβ serves as a tumor suppressor by inhibiting cell growth, and in later stages of disease, tumor cells escape this growth inhibition. As late stage cancer tends to be resistant to TGFβ-driven growth arrest signals and as TGFβ is a known inducer of EMT, TGFβ is proposed to be a facilitator of cancer progression during late stage disease [
24‐
26]. TGFβ induces EMT by up-regulating Snail1 via the Smad-dependent pathways [
27]. Mishra and colleagues have reviewed the complexity of TGFβ signaling during hepatocarcinogenesis, specifically as related to β2-Spectrin loss and stem cell malignant transformation [
15,
28‐
30].
As additional evidence linking EMT to TISCs, TGFβ regulates
Nanog expression, a transcription factor that contributes to self-renewal and cell fate determination in embryonic stem cells [
31,
32]. In prostate cancer, increased
Nanog expression is implicated in tumor progression, and the co-expression of Nanog and Oct4 promotes tumor-sphere formation [
4,
33,
34]. In colon cancer, increased Snail1 expression correlates to increased
Nanog expression [
35]. In human HCC cell lines, TGFβ regulates
CD133 expression, a marker of TISCs, through induction of epigenetic modifications of the
CD133 promoter [
23,
36].
Thus, several studies have demonstrated that TGFβ drives EMT through Snail1 up-regulation, and other studies have correlated EMT to the acquisition of TISC characteristics. What is lacking is an understanding of the mechanism of how liver cancer cells acquire TISC characteristics through EMT. Our hypothesis is that mesenchymal cells acquire TISC traits after EMT through Snail1-dependent mechanisms. In this report, we demonstrate that mesenchymal liver cancer cells (post-EMT) possess several TISC characteristics compared to epithelial cells. TGFβ induces EMT and TISC characteristics in epithelial cells through Snail1. In mesenchymal cells, knock-down of Snail1 results in loss of Nanog and reduction of TISC traits. In vivo studies demonstrate that Snail1 regulates tumor growth but does not fully control tumor initiation.
Methods
Cell Culture
Epithelial and mesenchymal murine liver cancer cells were cultured in Dulbecco's modified Eagle's medium (DMEM)/F12 (Sigma) supplemented with 10% fetal bovine serum as described [
37]. The human HCC cell line Huh7 was provided by Jianming Huh, Penn State College of Medicine and cultured as described [
36,
38]. The human HCC The human HCC cell lines MHCC97-L were provided by Xinwei Wang, National Cancer Institute, under agreement with the Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China and cultured as described [
39].
Transfections
For Snail1 transient knockdown, cells were transfected with 100 pM of Snail1 Stealth siRNA (Invitrogen) using Lipofectamine 2000 (Invitrogen). For Smad signaling inhibition, cells were transfected with 2 ug of DNA using Fugene 6 (Roche). To generate Snail1 knockdown stable transfectants, mesenchymal cells were transfected with Snail1 Mission shRNA lentivirus (Sigma) and selected with 2 ug/ml of puromycin.
Luciferase Assay
pCMV5-Smad7-HA (Plasmid 11733), pRK-Smad3ΔC (Plasmid 12626), and Nanog-Luc (Plasmid 16337) were provided by Addgene. Cells were plated in 12 well plates, incubated overnight, and transfected with the Nanog-Luc plasmid and Renilla for 24 hours (4:1 Nanog-Luc:Renilla ratio). Cells were washed with 1 × PBS, serum free starved for 2 hours, and treated with 5 ng/ml of TGFβ for 24 hours. Following cell lysis, luciferase activity was measured using the Dual Luciferase Assay Kit (Promega) and a Sirius Luminometer V3.1 (Zylux). Luciferase reading light units (RLU) were normalized to Renilla RLU and a fold change was calculated.
qRT-PCR
Trizol (Invitrogen) was used to isolate total RNA from cells according to manufacturer's protocol. Isolated RNA was quantified using the ND-1000 spectrophotometer (NanoDrop) and complementary single strand DNA was synthesized using the Omniscript RT Kit according to the manufacturers protocol (Qiagen). qPCR was performed using Taqman Gene Expression Assays and ABI-Prism 7700 Thermal Cycler (Applied Biosystems). Normalization was performed using
β-actin or
Gapdh as an endogenous control and relative gene expression was calculated using the comparative 2
(-ΔΔCt) method with SDS 2.2.2 software [
36].
Cell Viability Assays
Cell viability was performed using the XTT (2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) kit (Trevigen) according to the manufacturer's protocol. 5 × 103 cells were plated in 96-well plates, incubated for 24 hours at 37°C, and treated with specified agents at defined time points.
Western Blot Analysis
Cells were washed twice with ice cold 1XPBS and cell lysates were harvested by the addition of lysis buffer (40 nM Tris [pH 7.4], 150 mM NaCl, 10 mM ethylene diamine tetraccetic acid, 10% glycerol, 1% Triton X-100, 10 mM glycerophosphate, 1 mM Na3VO4, 1 mM phenylmethylsulfonyl fluoride) supplemented with protease inhibitor cocktail tablets (Roche). BCA protein assay (Thermo Fisher Scientific) was used to determine protein concentration as described [
40]. 30 ug of protein lysates were separated on a NuPAGE 4-12% Bis-Tris Gel (Invitrogen) and the separated proteins were transferred onto a polyvinylidene difluoride membrane (Invitrogen). After blocking for 60 min with 5% non-fat dry milk, membranes were incubated with the primary antibody overnight at 4°C followed by incubation with corresponding secondary antibody for 60 min at room temperature. The membranes were developed using enhance chemiluminescence solutions (Thermo Fisher Scientific) [
41].
Cell Migration Assay
The capability of tumor cell migration was assessed using a wound-healing assay. Confluent cell monolayers were manually wounded by scraping the cells with a 1,000 μL pipette tip down the center of the well. The cell culture medium was replaced and migration was assessed at 24 hours [
37].
Matrigel Invasion Assay
Cell invasion was assessed using 6-well Transwell permeable inserts with 8-μm pores (Corning) [
37]. In brief, 1 × 10
5 cells were cultured in a serum-free DMEM/F12 medium in an insert coated with Matrigel (BD). Below the insert, the chamber of 6-well plates contained DMEM/F12 supplemented with 10% FBS. Cells were incubated in a 37°C incubator for 48 hours and the number of cells that invaded across the membranes and fallen onto the bottom of the plate was counted.
Transcriptome analysis
Using the cell lines from the liver specific
Pten
-/-
model described [
37] P2E (epithelial) and P2M (mesenchymal) messenger RNA were analyzed using an Illumina mouse gene chip according to the manufacturer's protocol and as described [
37]. Housekeeping genes were used as standards to generate expression levels, and data analysis was conducted using 1.4-fold or greater change in expression with p < 0.05 as significant. The full complement of the expression data is available at
http://www.ncbi.nlm.nih.gov/geo (Accession number GSE18255).
The capability of self-renewal was assessed using Corning Ultra-Low Attachment Surface (Corning). 5 × 103 cells were seeded and incubated in a cell culture incubator for 1 week in DMEM/F12 supplemented with 10% FBS or serum free medium and phase-contrast images were obtained.
In vivo tumor growth assay
Cells were counted with trypan blue exclusion and suspended in a 1:3 dilution of Matrigel (Matrigel:DMEM/F12 supplemented with 10% FBS) [
36]. 1 × 10
4 and 1 × 10
5 cells/50 μL were injected subcutaneously into 10-week-old nude mice. Caliper measurements of tumor volume (length × width × height) were conducted every 2 days. After 3 weeks, mice were sacrificed for tumor analysis. All procedures were in compliance with our institution's guidelines for the use of laboratory animals and approved by the Penn State College of Medicine Institutional Animal Care and Use Committee.
Statistical Analysis
Microarray statistical analysis was performed as describe [
37]. Student t test was used comparing two groups. One-way ANOVA was used comparing multiple groups followed by Tukeys post-hoc test. All analysis with a p < 0.05 was considered significant.
Discussion
Although liver transplantation has significantly improved survival in patients with early stage HCC, the prognosis for late stage HCC remains poor [
45]. Causes of poor prognosis in late stage disease include invasive/metastatic disease and tumor recurrence after treatment. In breast cancer, EMT has been linked to TISC characteristics and resistant disease. Although this link between EMT and TISCs has been established in other cancers, including breast, prostate, nasopharyngeal, and colon cancer, this relationship has yet to be defined in HCC [
17,
22,
46]. One potential link between EMT and TISCs in liver cancer is TGFβ.
TGFβ has a dual role in HCC either as a tumor suppressor in early stages or tumor promoter in later stages [
15,
43]. One of the mechanisms of early neoplastic transformation is through the evasion of cytostatic effects of TGFβ [
43]. During the late stages of HCC tumorgenesis, TGFβ stimulates cellular invasion through the EMT program [
44].
TGFβ induces EMT through
Snail1, which represses
E-cadherin by binding to E-box promoter elements [
18,
19,
47]. In cancer patients, an EMT-phenotype transcriptome profile, with increased Snail1 expression, correlates with invasive tumors [
21,
48,
49]. In this report, TGFβ stimulation of epithelial liver cancer cells results in a mesenchymal phenotype with fibroblastoid appearance, loss of
E-cadherin, increased invasion and migration, and an up-regulation of Snail1. In addition, TGFβ treatment induces a TISC phenotype in epithelial cells. Although TGFβ-induced EMT generates TISC characteristics [
17,
22], the underlying mechanism has not yet been elucidated. Based on our results, we hypothesize that these TISC characteristics are Snail1 dependent. Inhibition of Snail1 causes the down-regulation of Nanog,
Bmi-1 and CD44, loss of a migration and self-renewal as evidenced by decreased tumor-sphere formation.
Another key regulatory signaling pathway known to induce EMT in liver cells is the Hedgehog (Hh) signaling pathway. Hh promotes EMT in response to chronic liver injury [
50]. In addition, Hh signaling has been suggested to play an important role in the maintenance of TISCs, and BMI-1, the polycomb group protein, may directly mediate Hh signaling in order to confer a self-renewal capacity in TISCs [
10,
46,
51]. However, within our system, we were unable to see significant differences of BMI-1 between epithelial and mesenchymal cells.
TGFβ also directly controls Nanog in human embryonic stem cells [
31]. Nanog is a key transcription factor that regulates self-renewal in stem cells [
4,
52]. Recent studies demonstrate that Nanog promotes TISC characteristics, and the down regulation of Nanog inhibits sphere formation and tumor development [
4,
34,
35,
53]. In this report, Nanog is up-regulated by TGFβ through Smad signaling. In addition, Snail1 directly regulates
Nanog promoter activity.
TISCs are proposed to initiate tumors. In our model, liver cancer cells with a mesenchymal phenotype demonstrate TISCs characteristics, including tumor-sphere formation and increased expression of CD44 and Nanog. We further investigated epithelial and mesenchymal phenotypes in human HCC, Huh7 and MHCC97-L cells. Accordingly, Huh7 cells follow an epithelial phenotype whereas MHCC97-L cells are more mesenchymal demonstrating increased
Snail1, Zeb1, Zeb2 mRNA expression, decreased E-cadherin expression, increased migration/invasion and increased tumorsphere formation [
38].
In our murine system, Snail1 inhibition resulted in loss of tumor-sphere formation, decreased expression of CD44 and Nanog, and decreased tumor growth. According to our in vitro results, Snail1 clearly regulates TISC characteristics. However, the loss of Snail1 is not sufficient to inhibit tumor initiation, as evidenced by in vivo results. These findings are not un-expected in that the proposed TISC-driven tumor initiation is an early event in tumorigenesis, and cells that acquire TISC characteristics after EMT are a late event in tumor progression. In addition, Snail1 is one of many regulators of EMT, and thus manipulation of multiple factors may be required to fully inhibit tumor initiation.
Competing interests
Dr. Rountree reports research support of less than $10,000 from Bayer Pharmaceuticals for un-related studies. Authors Dang, Ding, and Emerson report no competing interests.
Authors' contributions
HD carried out the molecular and in vivo studies and drafted the manuscript. WD assisted in molecular and in vivo studies and manuscript preparation. DE participated in molecular in vitro studies. CBR conceived of the study, and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.